Access cutting-edge uveal melanoma treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.
Access uveal melanoma specialists in Miami at no cost
This study follows strict safety protocols and ethical guidelines
All study-related uveal melanoma treatment provided free
This is a Phase 2/3, multi-arm, multi-stage, open-label study of human leukocyte antigen (HLA)-A\*02:01 negative participants with metastatic uveal melanoma (MUM) who will be randomized to receive either IDE196 + crizotinib or investigator's choice of treatment (pembrolizumab, ipilimumab + nivolumab, or dacarbazine).
Sponsor: IDEAYA Biosciences
Check if you qualify for this uveal melanoma clinical trial in Miami, FL
If you're searching for uveal melanoma treatment options in Miami, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced uveal melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.